PACB PEER ANALYSIS

Pacific Biosciences of California — metric-by-metric comparison with peers and the industry median

PACBPacific Biosciences of California

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

PACBIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	PACB	4DX	SN	ONCSM	MEDTR	ANGEN	Ind. Median
P/E	—	—	20.73●	122.41	596.83	—	26.82
P/B	214.56	-76.08●	2.50	13.36	1.08	1.32	2.50
EV/EBITDA	—	—	9.94●	25.46	10.93	34.77	15.54
P/S	3.17	249.46	2.10	7.66	1.18●	2.95	2.69

Financial Health
Metric	PACB	4DX	SN	ONCSM	MEDTR	ANGEN	Ind. Median
Current Ratio	5.65	6.57●	2.57	2.25	3.58	2.31	3.28
Debt/Equity	29,729.0%	-22.6%●	62.9%	35.0%	1.0%	28.1%	44.7%
NetDebt/EBITDA	-4.01●	0.71	1.72	0.42	-1.64	4.71	0.82

Profitability
Metric	PACB	4DX	SN	ONCSM	MEDTR	ANGEN	Ind. Median
Net Margin	-80.3%	-3,684.6%	10.1%●	6.3%	0.2%	-45.0%	-5.7%
ROE	-273.6%	—	12.1%	12.9%●	0.2%	-21.0%	-8.6%
ROA	-15.6%	-264.3%	6.1%	8.0%●	0.2%	-15.7%	-6.4%
EBITDA Margin	-66.6%	-818.8%	25.6%	30.6%●	9.4%	9.8%	5.2%

Growth + Dividend
Metric	PACB	4DX	SN	ONCSM	MEDTR	ANGEN	Ind. Median
Rev. Growth	5.0%	-26.0%	—	39.1%●	6.5%	11.7%	7.4%
NI Growth	—	—	—	—	-62.9%	—	16.7%
Div. Yield	—	—	3.5%●	0.0%	1.1%	0.0%	1.1%
Payout	—	—	52.8%	0.0%	656.3%	0.0%	39.0%

Valuation
Metric	PACB	VMD	CLPT	KIDS	CTKB	VREX	Ind. Median
P/E	—	32.98	—	—	—	—	26.82
P/B	214.56	3.41	28.23	1.43	1.81	0.95●	2.50
EV/EBITDA	—	9.31	—	—	—	—	15.54
P/S	3.17	1.71	13.10	1.99	2.91	0.52●	2.69

Financial Health
Metric	PACB	VMD	CLPT	KIDS	CTKB	VREX	Ind. Median
Current Ratio	5.65	1.22	5.79●	5.21	4.69	3.20	3.28
Debt/Equity	29,729.0%	8.6%●	337.5%	31.4%	11.1%	80.3%	44.7%
NetDebt/EBITDA	-4.01	0.05	-1.18	-8.36	10.20	-47.21●	0.82

Profitability
Metric	PACB	VMD	CLPT	KIDS	CTKB	VREX	Ind. Median
Net Margin	-80.3%	5.2%●	-71.6%	-16.3%	-36.2%	-9.6%	-5.7%
ROE	-273.6%	10.7%●	-149.7%	-11.6%	-20.9%	-16.2%	-8.6%
ROA	-15.6%	7.9%●	-47.1%	-8.2%	-15.9%	-6.8%	-6.4%
EBITDA Margin	-66.6%	18.5%●	-58.2%	-2.7%	-10.8%	-0.7%	5.2%

Growth + Dividend
Metric	PACB	VMD	CLPT	KIDS	CTKB	VREX	Ind. Median
Rev. Growth	5.0%	23.1%	26.0%●	14.5%	3.6%	3.6%	7.4%
NI Growth	—	21.2%	—	—	—	—	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PACB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.